News: How GSK's CEO Ignored His Own Worries and Wasted $16B on a Failed Diabetes Drug
Former CEO Jean-Pierre Garnier's 1999 failure to follow up on worries about heart attack deaths associated with Avandia was a strategic disaster, costing more than $16 billion.